At Crown Bioscience, we are constantly developing, evaluating, and utilizing innovative technologies, to serve the dynamic needs of your preclinical and translational studies. We provide end-to-end service to our customers, using the most advanced analysis and generate comprehensive data, utilizing machine intelligence to help you make better-informed decisions.
Apply the most appropriate in silico framework to your pharmacology data or historical datasets to elevate your study design and analysis, and to improve your chances of clinical success.
Leverage 2D and 3D bioluminescence and fluorescence optical imaging enabling in-life visualization of tumor growth and disease progression.
Integrate advanced statistics into your drug development projects to gain significant biological insight into your therapeutic candidate, with our expert team of bioinformaticians.
Rely on our experienced genomics services to deliver high quality, interpretable results using highly sensitive PCR-based, real-time PCR, and NGS technologies and advanced data analytics.